ArticleJournal of acquired immune deficiency syndromes (1999)2010

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy.

Akihiko Saitoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.